Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Czechia France Germany Greece Hungary Italy +3
  • A study testing sonlicromanol in adults with genetically confirmed mitochondrial DNA 3243A>G variant causing mitochondrial disease

    Recruiting

    3 1
    Denmark France Germany Italy The Netherlands
  • A study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder

    Recruiting

    3 1
    Investigated Drugs:
    Czechia Finland Germany Poland Romania Slovakia +1
  • A study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer

    Recruiting

    2 1 1 1
    Germany Italy Spain
  • A Study of Carboplatin Given Directly into the Abdomen After Surgery in Elderly and Frail Patients with Ovarian Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark
  • Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Greece +7
  • A study testing finerenone compared to placebo in patients with chronic kidney disease who are not taking renin-angiotensin-system inhibitors

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • A study to test the safety and effects of TLN-372 alone and with other cancer drugs in patients with advanced solid tumors with KRAS gene changes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • A Study of Zanubrutinib for Patients with Anti-MAG Antibody Neuropathy Associated with Blood Disorders or Abnormal Protein in the Blood

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • A Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria